Lisinopril and Hydrochlorothiazide
- Product NDC
- 55700-906
- 11-digit product format
- 557000906
- Labeler code
- 55700
- Product ID
- 55700-906_8a2be8bb-09c2-4ef4-8e79-a80460a940a9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide Tablets
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA204058
- Marketing category
- ANDA
- Marketing start
- 2021-03-18
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-906-30 | 55700090630 | 30 TABLET in 1 BOTTLE, PLASTIC (55700-906-30) | 30 tablet | 2021-03-18 | 0000-00-00 | No | No | Current |